Disease
Idiopathic Pulmonary Fibrosis
A progressive fibrosing interstitial lung disease of unknown cause managed with antifibrotic therapy.
Coverage in progress. AssetMemo has not yet run its full census for Chronic Cough in Idiopathic Pulmonary Fibrosis, so the assets listed for it are not complete.
Combined attributable cost
$8.8B+
Drug spend
Not yet sourced
Sum of 2 indications below.